The U.S. Food and Drug Administration (FDA) has cleared a modification for XACT's Ace Robotic system.
Ace combines image-based procedure planning and real-time monitoring with hands-free robotic insertion and nonlinear steering. The new FDA clearance now includes robotic insertion and steering of ablation probes during ablation procedures, and it features a 1.7-mm tip for high insertion accuracy, according to XACT.
The company plans to highlight Ace at the upcoming Society of Interventional Radiology meeting in Boston.
